Delivery Order SPE2DB22D3010-SPE2DB26FP0SQ
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,819.25 on August 25, 2025, for the supply of Topamax 200 mg tablets (60-count units). This firm fixed-price delivery order, which is expected to be completed by August 26, 2025, represents a competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the place of...
- The Defense Logistics Agency awarded a $7,981.11 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Topamax 200 mg on June 20, 2025, with an ultimate completion date of June 23, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Topamax 25 mg tablets (60-count) with a ceiling value of $1,606.98. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The order is scheduled for ultimate completion on June 17, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Topamax (topiramate) 50 mg tablets in quantities of 60 units, with a ceiling value of $3,052.09. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The contract is scheduled for ultimate completion by July 31, 2025, and represents a short-duration fulfillment of pharmaceutical requirements for federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,558.94 to AmerisourceBergen Drug Corp for the supply of Topamax 25 mg sprinkle capsules (60-count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Topamax 50 mg tablets. The contract has a ceiling value of $3,118.74 and a period of performance through April 1, 2024. AmerisourceBergen Drug Corp is the prime contractor and will deliver the pharmaceutical product from its corporate office in Conshohocken, Pennsylvania. This award is part of a larger indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,164.89 to AmerisourceBergen Drug Corp for 60 units of Topamax 25 mg Sprinkle Capsules on September 16, 2025, with an ultimate completion date of September 17, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of 1,000 units of Topiramate 100mg at a firm fixed price of $1,566.48. This is a non-set-aside, competitively awarded contract with an ultimate completion date of September 13, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order, which falls under a larger indefinite...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $24,597.74 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of Topamax 50 mg tablets. This contract is a task order issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to supply...
- The U.S. Defense Logistics Agency (DLA) awarded a $12,893.60 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TOPAMAX 50 MG TABLET 60S, a pharmaceutical product. This delivery order contract has an ultimate completion date of March 18, 2024 and was awarded on March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB26FP0SQDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at approximately $2,993 on October 21, 2025, for the supply of Topamax 100 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver a wide range of pharmaceutical products, medical supplies, brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This specific delivery order for Topamax, a neurological treatment medication, exemplifies the types of specialty medications the company regularly supplies through competitive federal procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 10/21/25 |